Realizing RNA Fragmentomics

We're discovering new biomarkers to advance next-generation diagnostics that provide deeper insights and improve more lives.

RiboMarker®: The Platform for RNA Biomarker Discovery

Our proprietary RiboMarker® platform uncovers novel biomarkers by analyzing RNA fragments that other approaches cannot detect through a combination of library construction, NGS, and AI-powered bioinformatics tools. RiboMarker’s enabling technology unlocks next-generation RNA analytes for broad diagnostic applications from liquid biopsies for oncology or infectious disease, to soil sampling.

Why RNA Fragmentomics?

If you’re missing RNA fragments, you’re missing RNA’s potential.

Complete Transcriptomics

RNA fragments hold dynamic biological information that is missed by traditional techniques. Analyzing RNA fragments provides rich insights into the transcriptome such as the progression of a disease, rather than simply its presence or absence.

Broad Diagnostic Applicability

Current techniques only see about 10% of RNA. Our RiboMarker platform can see the other 90%. Unlocking the ability to detect and analyze RNA fragments from virtually any biological sample means deeper insights and better diagnostics that ultimately help people live happier and healthier lives.

Complementary Analysis

While DNA analysis is ubiquitous in liquid biopsies and many diagnostic applications due to its ease-of-use, RNA fragmentomics is a powerful complementary technique that provides greater insight and accuracy than DNA analysis alone is capable of.

RNA NGS Products and Services

We offer a wide range of sequencing services and library preparation from extracted RNA or ready-to-sequence pooled libraries to customized products for your bioinformatic needs. We also provide library preparation kits available for online purchase or via PO.

Our Latest News and Insights

Keep up with the most recent company updates and our expert insights on RNA fragmentomics.

Ready to Help Realize RNA Fragmentomics?

We were founded on NIH funding and we are determined to bring the benefits of RNA fragmentomics to the world.

We are actively seeking collaboration with industry or research partners to correlate the rapidly growing wealth of novel RNA biomarkers with clinical outcomes.

Want to Discover More?